z-logo
open-access-imgOpen Access
Primary Adrenal Insufficiency due to Immune Checkpoint Inhibitors: More Common than We Thought
Author(s) -
Salinas Carlos,
Samtani Suraj,
Burotto Mauricio
Publication year - 2021
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1002/onco.13588
Subject(s) - medicine , adrenal insufficiency , primary adrenal insufficiency , immunotherapy , incidence (geometry) , adverse effect , immune system , population , intensive care medicine , pediatrics , immunology , oncology , optics , physics , environmental health
Immunotherapy has changed the treatment landscape for cancer patients; however, immune‐related adverse events, such as primary and secondary adrenal insufficiency, can be life threatening, with potential differences in population incidence. This letter to the editor reports a real‐world experience of Hispanic/Latino patients treated with immunotherapy and the incidence of adrenal insufficiency.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here